<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101573691</journal-id>
<journal-id journal-id-type="pubmed-jr-id">39703</journal-id>
<journal-id journal-id-type="nlm-ta">Cell Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">Cell Rep</journal-id>
<journal-title-group>
<journal-title>Cell reports</journal-title>
</journal-title-group>
<issn pub-type="epub">2211-1247</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28355569</article-id>
<article-id pub-id-type="pmc">5415377</article-id>
<article-id pub-id-type="doi">10.1016/j.celrep.2017.03.009</article-id>
<article-id pub-id-type="manuscript">NIHMS858469</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Severity of Demyelinating and Axonal Neuropathy Mouse Models Is Modified by Genes Affecting Structure and Function of Peripheral Nodes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Morelli</surname>
<given-names>Kathryn H.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN2">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Seburn</surname>
<given-names>Kevin L.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN2">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schroeder</surname>
<given-names>David G.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Spaulding</surname>
<given-names>Emily L.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dionne</surname>
<given-names>Loiuse A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cox</surname>
<given-names>Gregory A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Burgess</surname>
<given-names>Robert W.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN3">4</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>The Jackson Laboratory, Bar Harbor, ME 04609, USA</aff>
<aff id="A2"><label>2</label>Graduate School of Biomedical Science and Engineering, University of Maine, Orono, ME 04469, USA</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Correspondence: <email>robert.burgess@jax.org</email></corresp>
<fn id="FN2">
<label>3</label>
<p>Co-first author</p>
</fn>
<fn id="FN3">
<label>4</label>
<p>Lead Contact</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>17</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<day>28</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>03</day>
<month>5</month>
<year>2017</year>
</pub-date>
<volume>18</volume>
<issue>13</issue>
<fpage>3178</fpage>
<lpage>3191</lpage>
<!--elocation-id from pubmed: 10.1016/j.celrep.2017.03.009-->
<abstract id="Abs1">
<title>SUMMARY</title>
<p id="P1">Charcot-Marie-Tooth (CMT) disease is a clinically and genetically heterogeneous group of inherited polyneuropathies. Mutations in 80 genetic loci can cause forms of CMT, resulting in demyelination and axonal dysfunction. The clinical presentation, including sensory deficits, distal muscle weakness, and atrophy, can vary greatly in severity and progression. Here, we used mouse models of CMT to demonstrate genetic interactions that result in a more severe neuropathy phenotype. The cell adhesion molecule <italic>Nrcam</italic> and the Na<sup>+</sup> channel <italic>Scn8a</italic> (NaV1.6) are important components of nodes. Homozygous <italic>Nrcam</italic> and heterozygous <italic>Scn8a</italic> mutations synergized with both an <italic>Sh3tc2</italic> mutation, modeling recessive demyelinating Charcot-Marie-Tooth type 4C, and mutations in <italic>Gars</italic>, modeling dominant axonal Charcot-Marie-Tooth type 2D. We conclude that genetic variants perturbing the structure and function of nodes interact with mutations affecting the cable properties of axons by thinning myelin or reducing axon diameter. Therefore, genes integral to peripheral nodes are candidate modifiers of peripheral neuropathy.</p>
</abstract>
<abstract abstract-type="graphical" id="Abs2">
<title>Graphical abstract</title>
<p id="P2">
<graphic orientation="portrait" position="anchor" xlink:href="nihms858469u1.jpg"></graphic></p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>